Loading viewer...
annual_report
Format: PDF annual_report
Telix Pharmaceuticals held its Annual General Meeting on May 24, 2023, to update shareholders on company operations and activities. The presentation covers Telix's investigational pharmaceutical products, including Illuccix® (Ga-68 gozetotide injection), and discusses business developments, regulatory progress, and financial performance. This document provides summary information for shareholder review and should be read in conjunction with ASX continuous disclosure filings.
conference
33 Pages
Advance Auto Parts
annual_report
Zenith Bank
ADM 2007 Annual Report - Archer Daniels Midland
annual_reportannual_report
94 Pages
Archer Daniels Midland Company
Archer Daniels Midland 2006 Annual Report
annual_reportannual_report
68 Pages
Archer Daniels Midland